持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/11 | 10,330 | 10,370 | 10,120 | 10,120 | -180 | -1.7% | 36,800 |
2018/12/10 | 10,480 | 10,480 | 10,200 | 10,300 | -220 | -2.1% | 28,800 |
2018/12/07 | 10,340 | 10,580 | 10,250 | 10,520 | +180 | +1.7% | 45,500 |
2018/12/06 | 10,250 | 10,350 | 10,180 | 10,340 | +70 | +0.7% | 48,800 |
2018/12/05 | 10,060 | 10,270 | 10,060 | 10,270 | -10 | -0.1% | 37,800 |
2018/12/04 | 10,640 | 10,650 | 10,250 | 10,280 | -320 | -3% | 47,000 |
2018/12/03 | 10,400 | 10,650 | 10,400 | 10,600 | +290 | +2.8% | 60,900 |
2018/11/30 | 10,180 | 10,400 | 10,180 | 10,310 | +160 | +1.6% | 94,100 |
2018/11/29 | 10,080 | 10,300 | 10,080 | 10,150 | +170 | +1.7% | 54,600 |
2018/11/28 | 10,000 | 10,070 | 9,920 | 9,980 | +60 | +0.6% | 40,100 |
2018/11/27 | 10,020 | 10,020 | 9,890 | 9,920 | -80 | -0.8% | 37,200 |
2018/11/26 | 9,980 | 10,020 | 9,900 | 10,000 | +90 | +0.9% | 44,600 |
2018/11/22 | 9,730 | 9,930 | 9,730 | 9,910 | +220 | +2.3% | 36,300 |
2018/11/21 | 9,690 | 9,750 | 9,600 | 9,690 | -60 | -0.6% | 26,400 |
2018/11/20 | 9,600 | 9,760 | 9,600 | 9,750 | +70 | +0.7% | 18,900 |
2018/11/19 | 9,520 | 9,690 | 9,490 | 9,680 | +210 | +2.2% | 28,200 |
2018/11/16 | 9,500 | 9,500 | 9,370 | 9,470 | +10 | +0.1% | 18,000 |
2018/11/15 | 9,460 | 9,530 | 9,410 | 9,460 | -100 | -1% | 21,700 |
2018/11/14 | 9,600 | 9,650 | 9,510 | 9,560 | -30 | -0.3% | 35,900 |
2018/11/13 | 9,680 | 9,680 | 9,510 | 9,590 | -100 | -1% | 37,800 |
2018/11/12 | 9,700 | 9,850 | 9,680 | 9,690 | +40 | +0.4% | 52,500 |
2018/11/09 | 9,490 | 9,700 | 9,490 | 9,650 | +160 | +1.7% | 35,700 |
2018/11/08 | 9,270 | 9,500 | 9,270 | 9,490 | +370 | +4.1% | 43,100 |
2018/11/07 | 9,110 | 9,230 | 9,040 | 9,120 | -30 | -0.3% | 39,700 |
2018/11/06 | 8,830 | 9,220 | 8,830 | 9,150 | +170 | +1.9% | 27,600 |
2018/11/05 | 9,030 | 9,290 | 8,920 | 8,980 | -120 | -1.3% | 40,400 |
2018/11/02 | 9,150 | 9,150 | 9,000 | 9,100 | +20 | +0.2% | 27,000 |
2018/11/01 | 9,170 | 9,230 | 9,050 | 9,080 | +140 | +1.6% | 37,200 |
2018/10/31 | 8,990 | 9,000 | 8,830 | 8,940 | +20 | +0.2% | 33,400 |
2018/10/30 | 8,800 | 9,090 | 8,650 | 8,920 | +370 | +4.3% | 194,200 |
2018/10/29 | 8,690 | 8,750 | 8,540 | 8,550 | -140 | -1.6% | 33,800 |
2018/10/26 | 8,730 | 8,920 | 8,640 | 8,690 | +60 | +0.7% | 47,300 |
2018/10/25 | 8,830 | 8,840 | 8,600 | 8,630 | -310 | -3.5% | 63,900 |
2018/10/24 | 8,730 | 9,020 | 8,730 | 8,940 | +300 | +3.5% | 46,900 |
2018/10/23 | 8,780 | 8,840 | 8,630 | 8,640 | -290 | -3.2% | 30,800 |
2018/10/22 | 8,820 | 8,990 | 8,680 | 8,930 | +120 | +1.4% | 38,000 |
2018/10/19 | 8,730 | 8,840 | 8,730 | 8,810 | +10 | +0.1% | 23,600 |
2018/10/18 | 8,760 | 8,850 | 8,700 | 8,800 | +140 | +1.6% | 27,800 |
2018/10/17 | 8,580 | 8,730 | 8,580 | 8,660 | +90 | +1.1% | 30,200 |
2018/10/16 | 8,460 | 8,650 | 8,460 | 8,570 | +30 | +0.4% | 21,400 |
2018/10/15 | 8,570 | 8,640 | 8,520 | 8,540 | -120 | -1.4% | 33,000 |
2018/10/12 | 8,660 | 8,760 | 8,630 | 8,660 | -90 | -1% | 40,900 |
2018/10/11 | 8,800 | 8,850 | 8,680 | 8,750 | -270 | -3% | 52,500 |
2018/10/10 | 8,920 | 9,130 | 8,920 | 9,020 | +100 | +1.1% | 44,000 |
2018/10/09 | 9,190 | 9,200 | 8,890 | 8,920 | -320 | -3.5% | 44,400 |
2018/10/05 | 9,260 | 9,310 | 9,130 | 9,240 | -70 | -0.8% | 27,800 |
2018/10/04 | 9,430 | 9,430 | 9,200 | 9,310 | -30 | -0.3% | 26,400 |
2018/10/03 | 9,390 | 9,520 | 9,340 | 9,340 | -100 | -1.1% | 28,500 |
2018/10/02 | 9,400 | 9,500 | 9,300 | 9,440 | +120 | +1.3% | 33,500 |
2018/10/01 | 9,440 | 9,470 | 9,230 | 9,320 | -70 | -0.7% | 35,000 |
1451~
1500
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム